Features of management and treatment of elderly patients with type 2 diabetes mellitus

Type 2 diabetes is a serious burden on the health of the elderly, affecting approximately 25% of people over 65 years of age. It is expected that this percentage will increase sharply in the next decades due to the increase in life expectancy of the population. Diagnostic criteria for diabetes melli...

Full description

Saved in:
Bibliographic Details
Main Authors: L. Yu. Morgunov, E. V. Zemskova
Format: Article
Language:Russian
Published: Open Systems Publication 2022-10-01
Series:Лечащий Врач
Subjects:
Online Access:https://journal.lvrach.ru/jour/article/view/977
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849248481960525824
author L. Yu. Morgunov
E. V. Zemskova
author_facet L. Yu. Morgunov
E. V. Zemskova
author_sort L. Yu. Morgunov
collection DOAJ
description Type 2 diabetes is a serious burden on the health of the elderly, affecting approximately 25% of people over 65 years of age. It is expected that this percentage will increase sharply in the next decades due to the increase in life expectancy of the population. Diagnostic criteria for diabetes mellitus in elderly patients do not differ from the general population, there are several features of their management. The elderly population varies greatly in functional and cognitive abilities. These factors, along with an increased risk of hypoglycemia, falls and concomitant diseases, complicate the development of treatment regimens, therefore it is necessary to use a personality-oriented approach, minimizing the risk of excessive or insufficient therapy of diabetes, since the use of antidiabetic drugs in the elderly is associated with significant risk. The prevalence of diabetes mellitus significantly increases after the age of 80 with insufficient physical activity, alcohol consumption, a history of cardiovascular diseases, visceral obesity and hypertension. Cognitive impairment is 2 times more common in elderly people with diabetes. In addition to micro- and macrovascular lesions, a complication of diabetes in the elderly is also sarcopenia, which has a negative impact on the physical and psychosocial health of patients with diabetes and worsens their quality of life. Age-related metabolic changes and emerging kidney pathology predispose elderly people to an increased risk of developing diabetes mellitus and diabetic nephropathy, respectively. Despite the available therapy, a significant number of elderly patients with diabetic nephropathy have progressive renal failure and adverse cardiac outcomes, therefore, research is needed to study methods for early detection of diabetic nephropathy and new therapeutic interventions. Among the elderly with diabetes, individuals with poor glycemic control are at higher risk of cardiovascular events. Elderly patients have greater variability in glycemia and are more prone to arrhythmias, but active glucose control can reduce the risk of severe arrhythmia. Treatment of diabetes in elderly patients with heart failure can be a difficult task, taking into account numerous concomitant diseases, primarily chronic kidney disease. The complexity of treatment regimens, the clinical characteristics of patients and the ability of heart failure therapy to influence glucose metabolism and, conversely, the potential of some antidiabetic agents to modulate its outcomes are problems that need to be solved within the framework of an individual approach. Elderly men suffering from diabetes, for the prevention and treatment of osteoporosis, smoking cessation, glycemic control, regular exercise, active prevention and treatment of complications of osteoporosis, as well as testosterone replacement therapy are necessary. In elderly people, it is necessary to use individual pharmacotherapy with hypoglycemic drugs with a low risk of hypoglycemia and proven safety for the cardiovascular system, avoiding excessive treatment and simplifying therapy regimens. Glycemic targets in the elderly as part of individual treatment may be revised. Intensive treatment of elderly people with diabetes is common, creating an increased risk of adverse events such as hypoglycemia and hospitalization due to medication errors. Those receiving many drugs belong to the older age group, have numerous diseases, including kidney failure and dementia. In such patients, it is permissible to de-intensify therapy or even completely cancel hypoglycemic drugs without significantly worsening their glycemic control.
format Article
id doaj-art-77b8f3287b1a4dbdbcd2631f2d34b942
institution Kabale University
issn 1560-5175
2687-1181
language Russian
publishDate 2022-10-01
publisher Open Systems Publication
record_format Article
series Лечащий Врач
spelling doaj-art-77b8f3287b1a4dbdbcd2631f2d34b9422025-08-20T03:57:51ZrusOpen Systems PublicationЛечащий Врач1560-51752687-11812022-10-01110889510.51793/OS.2022.25.10.014972Features of management and treatment of elderly patients with type 2 diabetes mellitusL. Yu. Morgunov0E. V. Zemskova1Federal State Autonomous Educational Institution of Higher Education Peoples' Friendship University of Russia, Medical InstituteFederal State Autonomous Educational Institution of Higher Education Peoples' Friendship University of Russia, Medical InstituteType 2 diabetes is a serious burden on the health of the elderly, affecting approximately 25% of people over 65 years of age. It is expected that this percentage will increase sharply in the next decades due to the increase in life expectancy of the population. Diagnostic criteria for diabetes mellitus in elderly patients do not differ from the general population, there are several features of their management. The elderly population varies greatly in functional and cognitive abilities. These factors, along with an increased risk of hypoglycemia, falls and concomitant diseases, complicate the development of treatment regimens, therefore it is necessary to use a personality-oriented approach, minimizing the risk of excessive or insufficient therapy of diabetes, since the use of antidiabetic drugs in the elderly is associated with significant risk. The prevalence of diabetes mellitus significantly increases after the age of 80 with insufficient physical activity, alcohol consumption, a history of cardiovascular diseases, visceral obesity and hypertension. Cognitive impairment is 2 times more common in elderly people with diabetes. In addition to micro- and macrovascular lesions, a complication of diabetes in the elderly is also sarcopenia, which has a negative impact on the physical and psychosocial health of patients with diabetes and worsens their quality of life. Age-related metabolic changes and emerging kidney pathology predispose elderly people to an increased risk of developing diabetes mellitus and diabetic nephropathy, respectively. Despite the available therapy, a significant number of elderly patients with diabetic nephropathy have progressive renal failure and adverse cardiac outcomes, therefore, research is needed to study methods for early detection of diabetic nephropathy and new therapeutic interventions. Among the elderly with diabetes, individuals with poor glycemic control are at higher risk of cardiovascular events. Elderly patients have greater variability in glycemia and are more prone to arrhythmias, but active glucose control can reduce the risk of severe arrhythmia. Treatment of diabetes in elderly patients with heart failure can be a difficult task, taking into account numerous concomitant diseases, primarily chronic kidney disease. The complexity of treatment regimens, the clinical characteristics of patients and the ability of heart failure therapy to influence glucose metabolism and, conversely, the potential of some antidiabetic agents to modulate its outcomes are problems that need to be solved within the framework of an individual approach. Elderly men suffering from diabetes, for the prevention and treatment of osteoporosis, smoking cessation, glycemic control, regular exercise, active prevention and treatment of complications of osteoporosis, as well as testosterone replacement therapy are necessary. In elderly people, it is necessary to use individual pharmacotherapy with hypoglycemic drugs with a low risk of hypoglycemia and proven safety for the cardiovascular system, avoiding excessive treatment and simplifying therapy regimens. Glycemic targets in the elderly as part of individual treatment may be revised. Intensive treatment of elderly people with diabetes is common, creating an increased risk of adverse events such as hypoglycemia and hospitalization due to medication errors. Those receiving many drugs belong to the older age group, have numerous diseases, including kidney failure and dementia. In such patients, it is permissible to de-intensify therapy or even completely cancel hypoglycemic drugs without significantly worsening their glycemic control.https://journal.lvrach.ru/jour/article/view/977diabetes mellituselderly patientscomplicationshypoglycemiadeintensification of treatment
spellingShingle L. Yu. Morgunov
E. V. Zemskova
Features of management and treatment of elderly patients with type 2 diabetes mellitus
Лечащий Врач
diabetes mellitus
elderly patients
complications
hypoglycemia
deintensification of treatment
title Features of management and treatment of elderly patients with type 2 diabetes mellitus
title_full Features of management and treatment of elderly patients with type 2 diabetes mellitus
title_fullStr Features of management and treatment of elderly patients with type 2 diabetes mellitus
title_full_unstemmed Features of management and treatment of elderly patients with type 2 diabetes mellitus
title_short Features of management and treatment of elderly patients with type 2 diabetes mellitus
title_sort features of management and treatment of elderly patients with type 2 diabetes mellitus
topic diabetes mellitus
elderly patients
complications
hypoglycemia
deintensification of treatment
url https://journal.lvrach.ru/jour/article/view/977
work_keys_str_mv AT lyumorgunov featuresofmanagementandtreatmentofelderlypatientswithtype2diabetesmellitus
AT evzemskova featuresofmanagementandtreatmentofelderlypatientswithtype2diabetesmellitus